Derma Sciences Inc. (DSCI) Swings to Q4 Profit
Derma Sciences Inc. (NASDAQ: DSCI) reports Q4 EPS of $0.01, versus $0.12 reported for the same period a year ago. Revenue for the quarter was $13.65 million, compared to $12.56 million in Q408.
You May Also Be Interested In
- Tesla (TSLA) Offers to Acquire SolarCity (SCTY) for $26.50-$28.50/Share
- Accenture (ACN) Reports In-Line Q3 EPS; Boosts FY16 EPS Outlook
- Merrill Lynch Will Pay $415M to Settle SEC Investigation (BAC)
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!